SRSF4 Antibody

What validation criteria are critical for ensuring SRSF4 antibody specificity in western blot assays?

To confirm antibody specificity, researchers must perform three parallel validation steps:

• Knockout/Knockdown Controls: Use tissue or cell lysates from SRSF4-deficient models (e.g., cardiac-specific Srsf4 KO mice ). Lack of signal in KO samples confirms target specificity.

• Cross-Reactivity Profiling: Test reactivity against homologous proteins (e.g., SRSF6 or SRSF2) using overexpression lysates.

• Application-Specific Optimization: Adjust blocking buffers (e.g., 5% BSA vs. non-fat milk) and antibody dilution ratios (1:500–1:2,000) to minimize nonspecific bands .

For example, the study by Martín-García et al. validated SRSF4 antibodies in cardiomyocytes using KO heart lysates, observing complete signal loss in immunoblots .

How should researchers select SRSF4 antibodies for cross-species studies?

Prioritize antibodies validated for phylogenetic conservation. SRSF4 shares 92% amino acid identity between humans and mice, but critical epitopes may differ. Key considerations:

• Immunogen Alignment: Use tools like Clustal Omega to compare target species’ SRSF4 sequences with the immunogen sequence.

• Empirical Testing: Validate reactivity in target species via immunofluorescence (IF) and immunoprecipitation (IP). For instance, Aviva Systems Biology’s C-terminal antibody (ARP75112_P050) detects human and murine SRSF4 but not rat isoforms .

What methodological steps mitigate false positives in SRSF4 immunohistochemistry?

Optimize protocols using:

• Antigen Retrieval: Citrate buffer (pH 6.0) at 95°C for 20 minutes enhances epitope accessibility in FFPE tissue.

• Multiplex Validation: Combine IF with RNAscope® in situ hybridization for SRSF4 mRNA. Co-localization confirms antibody accuracy .

• Threshold Quantification: Use H-score analysis to differentiate low-abundance SRSF4 signals from background (e.g., H-score <50 deemed negative).

How does SRSF4 antibody selection impact RNA-protein interaction studies like iCLIP?

iCLIP (individual-nucleotide-resolution cross-linking and immuno-precipitation) requires antibodies that recognize native, non-denatured SRSF4. Critical factors:

• Conformational Sensitivity: Antibodies targeting linear epitopes (e.g., MyBioSource MBS224468) may fail in native IP. Use antibodies raised against full-length proteins (e.g., BosterBio PB9563) .

• UV Crosslinking Efficiency: Validate antibody performance post-crosslinking via immunoblotting. The PMC study achieved 80–200 nt RNA fragments using a GFP-tagged SRSF4 antibody .

Table 1: Antibody Performance in iCLIP Workflows

What experimental strategies resolve contradictions in SRSF4’s role in RNA splicing vs. stability?

The PMC study identified SRSF4’s dual roles:

• Splicing Regulation: Traditional view links SRSF4 to alternative splicing via RS domain-mediated interactions.

• RNA Stabilization: iCLIP data revealed SRSF4 binds and stabilizes lncRNA GAS5, preventing nonsense-mediated decay (NMD) .

Methodological Approach:

• Conditional Knockout Models: Compare splicing (vast-tools) and RNA stability (actinomycin D chase) in Srsf4−/− vs. WT cardiomyocytes.

• Dose-Response Experiments: Titrate SRSF4 expression using modRNA to dissect threshold effects on splicing vs. stability pathways.

How can SRSF4 antibodies elucidate its role in glucocorticoid receptor (GR)-mediated hypertrophy?

The PMC study workflow:

• Co-IP/ChIP: Immunoprecipitate SRSF4 from cardiomyocyte lysates and probe for GR association.

• Functional Rescue: Transfect SRSF4 KO cells with wild-type or RS domain-deleted SRSF4 modRNA. Quantify GR target genes (Gilz, Fkbp5) via qRT-PCR .

• Subcellular Fractionation: Compare SRSF4 localization (nucleus vs. cytoplasm) under dexamethasone stimulation.

Table 2: GR Activity in SRSF4-Deficient Models

What orthogonal assays validate SRSF4 antibody specificity in single-cell RNA-seq?

Integrate antibody-based protein detection with transcriptomic data:

• CITE-seq: Tag SRSF4 with oligonucleotide-conjugated antibodies (e.g., BioLegend TotalSeq™-A).

• Correlation Analysis: Compute Pearson’s r between antibody-derived SRSF4 signal and SRSF4 mRNA counts per cell. r >0.7 indicates high specificity .

How do researchers assess SRSF4’s isoform-specific functions using antibodies?

SRSF4 has two major isoforms:

• Isoform 1: Full-length (56.7 kDa).

• Isoform 2: Truncated (42 kDa) lacking RS domain.

Experimental Design:

• Isoform-Specific Antibodies: Use Aviva’s C-terminal antibody (detects both isoforms) vs. N-terminal antibodies (isoform 1-specific).

• Functional Knockdown: siRNA targeting isoform 1 vs. pan-SRSF4 siRNA. Measure GAS5 stability and GR activity .

Methodological Recommendations

• Antibody Validation Pyramid: Prioritize KO validation > cross-species reactivity > application-specific optimization.

• Data Triangulation: Combine antibody-based assays (western blot, IF) with orthogonal methods (RNA-FISH, CRISPRi).

• Contradiction Resolution: Use dose-response models and compartment-specific analyses to dissect pleiotropic roles.